Positive 12-Month Data for NervAlign Nerve Guide Matrix
Filed with ASX · · 4 pages · English
Summary by 6ix AI
The study showed that animals treated with the NervAlign matrix exhibited similar walking ability and nerve function recovery compared to those treated with an autologous nerve graft. Preliminary analysis indicated successful regrowth of blood vessels and nerve fibers, with further assessments planned for additional animals in the coming months. The results are part of an ongoing study aimed at evaluating the effectiveness of the NervAlign matrix in nerve repair, which is not yet approved for sale.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from Renerve
- Positive FDA Feedback on NervAlign Nerve Guide Matrix
- ReNerve AGM Presentation
- ReNerve completes first cases in Hong Kong and Malaysia
- ReNerve and RMIT awarded $499k grant
- ReNerve Secures Marketing Approval in India
Follow Renerve into a list and get an email when it puts out news.
Follow Renerve